Abstract
Regarding the peritonitis: a serious reverse disease of CAPD therapy, HPLC was applied to find any distinction of peritonitis effluent. The infected effluent group showed one increased peak (Peak B) and one decreased peak (Peak C) against normal effluent group. Isolation of Peak B resulted in two types of component and either type belonged to each patient. And the Peak C was identified to be one of furan derivatives: furoyiglycine. This systematic HPLC analysis of CAPD effluent with unknown and nonspecific substances would be expected to be an useful diagnostic tool for a disease sympton.
